DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) insider James P. Shaughnessy sold 7,500 shares of DocuSign stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.17, for a total transaction of $676,275.00. Following the completion of the transaction, the insider now directly owns 43,781 shares in the company, valued at approximately $3,947,732.77. The trade was a 14.63 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Shares of DocuSign stock traded up $0.41 on Thursday, reaching $90.35. 1,629,510 shares of the company were exchanged, compared to its average volume of 3,016,365. The company has a market capitalization of $18.25 billion, a price-to-earnings ratio of 18.63, a PEG ratio of 8.72 and a beta of 0.92. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The company has a 50-day moving average of $84.77 and a 200 day moving average of $67.26.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new stake in shares of DocuSign in the third quarter valued at approximately $28,000. Brooklyn Investment Group bought a new stake in DocuSign in the 3rd quarter valued at $33,000. Reston Wealth Management LLC acquired a new stake in DocuSign during the 3rd quarter valued at $47,000. Wilmington Savings Fund Society FSB acquired a new stake in DocuSign during the 3rd quarter valued at $51,000. Finally, nVerses Capital LLC bought a new position in DocuSign during the second quarter worth $48,000. 77.64% of the stock is owned by institutional investors.
DOCU has been the topic of several research reports. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $90.00 price objective (up from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Citigroup boosted their price target on DocuSign from $87.00 to $113.00 and gave the company a "buy" rating in a report on Friday, December 6th. Hsbc Global Res upgraded DocuSign to a "moderate sell" rating in a report on Friday, December 6th. Piper Sandler boosted their target price on DocuSign from $60.00 to $90.00 and gave the company a "neutral" rating in a research note on Friday, December 6th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of DocuSign in a research report on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $92.45.
View Our Latest Report on DOCU
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.